VA Office of Research and Development
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, VA Office of Research and Development sits in the top decile of US sponsors by registered trial count (#11 of 15,751 sponsors by registered trial count).
VA Office of Research and Development: 1,668 sponsored US clinical trials, 291 recruiting.
VA Office of Research and Development sponsors 1,668 registered US clinical trials on ClinicalTrials.gov, 291 of them currently recruiting, and 1,108 completed. 124 of these trials are in Phase 3-4 (later-stage) and 236 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is PTSD, with 28 trials.
Top-decile sponsor footprint
VA Office of Research and Development ranks in the top decile of sponsors by registered trial count (#11 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,668 total, page 27 of 34
Combined Neural and Behavioral Therapies to Enhance Stroke Recovery
NCT00929656
Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis
NCT01560780
Retinal Vessel Measurements as Clinically Useful Predictors in Veterans
NCT01772173
Integrated Alcohol Disorder and PTSD Treatment
NCT01601067
Effects of Exercise Intervention on Aging-related Motor Decline
NCT01787292
Stroke Self-Management: Effect on Function and Stroke Specific Quality of Life
NCT01507688
Vitamin D3 Supplementation for Low-Risk Prostate Cancer: A Randomized Trial
NCT01759771
Cognitive Behavioral Therapy (CBT) for PTSD in Veterans With Co-Occurring SUDs
NCT01357577
Exposure Therapy For Veterans With PTSD And Panic Attacks
NCT01033136
Multimodal Exercises to Improve Leg Function After Spinal Cord Injury
NCT01740128
Inflammation in Chronic Kidney Disease and Cardiovascular Disease - The Role of Genetics and Interleukin-1 Receptor Antagonist (IL-1ra)
NCT00897715
Telemedicine Intervention to Improve Physical Function
NCT01639469
Using Stories to Address Disparities in Hypertension
NCT01276197
Acceptance-based Group Intervention for Binge Eating
NCT01757847
Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans
NCT01590277
Evaluation of VLER-Indiana Health Information Exchange Demonstration Project
NCT01446705
Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI
NCT01670526
VA Augmentation and Switching Treatments for Improving Depression Outcomes
NCT01421342
Health Behavior Change for Hospitalized Veterans
NCT01602172
Novel Therapeutics in Posttraumatic Stress Disorder (PTSD): A Randomized Clinical Trial of Mifepristone
NCT01739335
Investigations of the Optimum Serum Bicarbonate Level in Renal Disease.
NCT01574157
Vestibular Rehabilitation and Dizziness
NCT01729039
Behavioral Activation Therapy for Rural Veterans With Diabetes and Depression
NCT01572389
A Randomized Cross Over Trial of Two Treatments for Sleep Apnea in Veterans With Post-Traumatic Stress Disorder
NCT01569022
MISSION-Vet HUD-VASH Implementation Study
NCT01430741
PCI Alternative Using Sustained Exercise
NCT03520400
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
NCT01350479
IOK Treatment Study
NCT01605799
Reducing Dyskinesia in Parkinson's Disease With Omega-3 Fatty Acids
NCT01563913
Targeted Intervention to Improve Medication Adherence in Cognitively Impaired Patients With HF (TARGET)
NCT01602731
Stroke Swallowing Screening Tool Validation
NCT01559649
Cultures Before and After Decolonization in Community Dwelling Adults With Current S. Aureus Colonization
NCT04222699
Using Peer Mentors to Support PACT Team Efforts to Improve Diabetes Control
NCT01651117
rTMS for the Treatment of Chronic Pain in GW1 Veterans
NCT01608321
A Randomized Trial of Medical and Surgical Treatments for Patients With GERD Symptoms That Are Refractory to Proton Pump Inhibitors
NCT01265550
Maintenance After Initiation of Nutrition TrAINing
NCT01357551
Tailored Activity Program-Veterans Affairs
NCT01357564
Biomechanical Validation of the Transfer Assessment Instrument (TAI)
NCT01183546
Motivational Interviewing to Prevent Suicide in High Risk Veterans
NCT01544127
Titrated Disease Management for Patients With Hypertension
NCT01390272
Randomized Trial to Test the "Coordinated Care for Health Promotion and Activities in Parkinson's Disease" Intervention in the VA
NCT01532986
The Effectiveness of rTMS in Depressed VA Patients
NCT01191333
Resistance Training and Testosterone After Spinal Cord Injury
NCT01652040
Group Treatment for PTSD: A Randomized Clinical Trial With Veterans
NCT01544088
Preparing Older Veterans With Serious and Chronic Illness for Decision Making
NCT01550731
Preventing Violence Among Veterans in Substance Use Disorder Treatment
NCT01337973
Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With BPH and LUTS
NCT01589263
Functional Vision in TBI
NCT01214070
Evaluation of Peer Telephone Cessation Counseling for Smokers
NCT01359371
The Role of Ghrelin in Cancer Cachexia
NCT01505764
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 89 |
| Phase 2 | 147 |
| Phase 3 | 55 |
| Phase 4 | 69 |
Therapeutic Areas
What is open in the VA Office of Research and Development pipeline
291 recruiting of 1,668 indexed (17% open); 1,108 completed (66%).
Phase mix: 124 late (III/IV) vs 236 early (I/II) (early-phase heavy).
Top condition: PTSD (28 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.